Chia-chyi Liu

Miaoli, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

VP1-141 is a determinant of a Vero cell-adapted Coxsackievirus A10 for vaccine development.

VP1-141 is a determinant of a Vero cell-adapted Coxsackievirus A10 for vaccine development.

Journal: PLoS neglected tropical diseases
Published: September 30, 2025

Propagation and immunological characterization of three enterovirus D68 strains using serum-free HEK293A suspension cell culture.

Propagation and immunological characterization of three enterovirus D68 strains using serum-free HEK293A suspension cell culture.

Journal: Vaccine
Published: August 10, 2025

Enhanced construction of a bivalent adenovirus-based vaccine for preventing childhood pathogens: Human respiratory syncytial virus and norovirus.

Enhanced construction of a bivalent adenovirus-based vaccine for preventing childhood pathogens: Human respiratory syncytial virus and norovirus.

Journal: SLAS technology
Published: October 03, 2024

Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development.

Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development.

Journal: Vaccine: X
Published: May 31, 2024

The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.

The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: February 23, 2023

Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.

Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.

Journal: Virus research
Published: December 20, 2022

Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column.

Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column.

Journal: Journal of chromatography. A
Published: July 17, 2022

The uncoating of EV71 in mature late endosomes requires CD-M6PR.

The uncoating of EV71 in mature late endosomes requires CD-M6PR.

Journal: Biology open
Published: June 03, 2022

Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges.

Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges.

Journal: Pharmaceutics
Published: April 02, 2022

Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies.

Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies.

Journal: Expert opinion on drug discovery
Published: August 12, 2021

Production of Multi-Subtype Influenza Virus-Like Particles by Molecular Fusion with BAFF or APRIL for Vaccine Development.

Production of Multi-Subtype Influenza Virus-Like Particles by Molecular Fusion with BAFF or APRIL for Vaccine Development.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 13, 2020

Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.

Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.

Journal: Vaccine
Published: November 03, 2018
Showing 1-12 of 43

Last Updated: 09/26/2026